Skip to main content
. 2019 Feb 6;9:4. doi: 10.1038/s41387-019-0072-2

Fig. 2. Inhibitory effect of GLP-1 antagonist on IES.

Fig. 2

a Blood glucose during OGTT: 0 min, Ex (9–39)/Ex (9–39) + IES vs. Sham or IES, p = 0.000; 15 min, Ex (9–39)/Ex (9–39) + IES vs. IES,  p< 0.05; 30 min, Ex (9–39)/Ex (9–39) + IES /Sham vs. IES, p < 0.05; 60 min and 90 min, Ex (9–39)/Ex (9–39) + IES /Sham vs. IES, p < 0.05, Ex (9–39) + IES vs. Sham, p < 0.05; 120 min, Ex (9–39)/Sham vs. IES, p < 0.05, Ex (9–39)/Ex (9–39) + IES vs. Sham, p < 0.01. b Area under curve of blood glucose during OGTT (15–120 min), Ex (9–39)/Ex (9–39) + IES /Sham vs. IES, *p < 0.05, #p < 0.01. GLP-1, glucagon-like peptide-1; IES, intestinal electrical stimulation; OGTT, oral glucose tolerance test; AUC, area under curve; BG, blood glucose; ex (9–39), Exendin (9–39), GLP-1 antagonist